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Abstract
Background:  D-type simian retrovirus-2 (SRV-2) causes an AIDS-like immune deficiency
syndrome (SAIDS) in various macaque species. SAIDS is often accompanied by retroperitoneal
fibromatosis (RF), an aggressive fibroproliferative disorder reminiscent of Kaposi's sarcoma in
patients with HIV-induced AIDS. In order to determine the association of SRV-2 subtypes with
SAIDS-RF, and study the evolution and transmission of SRV-2 in captive macaque populations, we
have molecularly characterized the env gene of a number of SRV-2 isolates from different macaque
species with and without RF.
Results: We sequenced the env gene from eighteen SRV-2 isolates and performed sequence
comparisons and phylogenetic analyses. Our studies revealed the presence of six distinct subtypes
of SRV-2, three of which were associated with SAIDS-RF cases. We found no association between
SRV-2 subtypes and a particular macaque species. Little sequence variation was detected in SRV-2
isolates from the same individual, even after many years of infection, or from macaques housed
together or related by descent from a common infected parent. Seventy-two amino acid changes
were identified, most occurring in the larger gp70 surface protein subunit. In contrast to the
lentiviruses, none of the amino acid variations involved potential N-linked glycosylation sites.
Structural analysis of a domain within the gp22/gp20 transmembrane subunit that was 100%
conserved between SRV-2 subtypes, revealed strong similarities to a disulfide-bonded loop that is
crucial for virus-cell fusion and is found in retroviruses and filoviruses.
Conclusion:  Our study suggests that separate introductions of at least six parental SRV-2
subtypes into the captive macaque populations in the U.S. have occurred with subsequent
horizontal transfer between macaque species and primate centers. No specific association of a
single SRV-2 subtype with SAIDS-RF was seen. The minimal genetic variability of the env gene within
a subtype over time suggests that a strong degree of adaptation to its primate host has occurred
during evolution of the virus.
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Background
Type D simian retroviruses (SRV) are Betaretroviruses
which have been etiologically linked to a simian acquired
immune deficiency syndrome (SAIDS) of varying severity
in several Asian macaque species. SRV infections are
found in wild-caught macaques and have been endemic
in captive macaque populations in the National Primate
Research Centers (NPRC) in the United States. To date,
five macaque SRV serogroups have been identified. All of
the Type D SRVs are genetically and serologically related
to the original prototype, the Mason-Pfizer monkey virus
(MPMV), which was isolated from breast tumor tissue of
a rhesus macaque (M. mulatta) in 1970 [1]. MPMV
belongs to the SRV-3 serogroup and has been completely
sequenced [2]. The prototype SRV genomic structure con-
sists of only four genes flanked by LTRs on the 3' and 5'
ends: the gag,prt,pol, and env genes encode the viral core
proteins, the viral protease, the reverse transcriptase/
endonuclease/integrase, and the envelope glycoproteins,
respectively.
The SRV-1 serotype was first identified in the early 1980's
in endemic infections of rhesus macaques at the Califor-
nia NPRC [3] and in rhesus macaques, Taiwanese rock
macaques (M. cyclopis) and cynomolgus macaques (M.
fascicularis) at the New England NPRC [4]. A California
isolate, D1/RHE/CA, was obtained from a rhesus
macaque [5] and has been completely sequenced [6]. A
New England isolate, D1/CYC/NE, was obtained from a
Taiwanese rock macaque [7]. Restriction enzyme analysis
indicated that all three macaque species infected with
SRV-1 at the New England NPRC contained the same SRV-
1 subtype, presumably from the introduction of the virus
into the colony from a single event [8].
The SRV-2 serotype was identified in the early 1980's in
endemic infections of pig-tailed macaques (M. nemest-
rina), cynomolgus macaques, and Japanese macaques (M.
fuscata) at the Washington NPRC [9-11], and in rhesus
[12] and Celebes black macaques (Macaca nigra) [13] at
the Oregon NPRC. Sequence analysis of SRV-2 isolates
from a Celebes black macaque (D2/CEL/OR) [14] and a
rhesus macaque (D2/RHE/OR) [15,16], both from the
Oregon NPRC, demonstrated the presence of distinct
SRV-2 subtypes. Partial sequence analysis of the env gene
of an additional SRV-2 isolate from a pig-tailed macaque
from the Washington NPRC (D2/MNE/WA) revealed a
close similarity to the D2/RHE/OR isolate [17].
Differences in pathogenicity have been reported for differ-
ent isolates within SRV serotypes. Such differences seem
to depend on the virus subtype and the macaque species
of the infected host. The SRV-1 isolate D1/RHE/CA, for
example, was significantly more pathogenic in rhesus
macaques than the D1/CYC/NE isolate [18,19], and dif-
ferences in cell tropisms as a possible cause for such vary-
ing pathogenicity have been identified [20,21]. The SRV-2
isolate, D2/CEL/OR, caused severe immunodeficiency in
Celebes black macaques but did not cause any symptoms
when transmitted to rhesus macaques [13]. The D2/RHE/
OR SRV-2 isolate was associated with mild immunodefi-
ciency disease in rhesus macaques but caused severe fatal
immunodeficiency disease in Japanese macaques. Fur-
thermore, a closely related variant, D2/RHE/OR/V1, iso-
lated from another rhesus macaque in the same
endemically infected colony, caused severe illness in rhe-
sus macaques [15]. A total of seventeen amino acid differ-
ences was detected between the two SRV-2 variants of
which ten were located in the env gene. It was speculated
that amino acid differences in the env gene could affect
virus tropism and play an important role in determining
pathogenicity.
Epidemics of SRV-2 associated SAIDS in pig-tailed
macaques at the Washington NPRC and Celebes black
macaques at the Oregon NPRC in the late 1970's and early
1980's were associated with a peculiar fibroproliferative
syndrome, histologically defined as retroperitoneal
fibromatosis (RF). RF is characterized by the aggressive
proliferation of vascular fibrous tissue subadjacent to the
peritoneum covering the ileocecal junction and the asso-
ciated mesenteric lymph nodes. Two forms of RF have
been recognized: the localized form in which fibroprolif-
erative lesions occur in multicentric isolated nodules and
the progressive form in which fibromatosis extends
throughout the abdominal cavity [9]. In some animals,
the localized form occured subcutaneously (subcutane-
ous fibromatosis (SF)) rather than in the usual abdominal
location [22]. Because of its multicentric nature and its
vascular and fibroproliferative features in a setting of pro-
found immunodeficiency, RF and SF bear strong resem-
blance to AIDS-related Kaposi's sarcoma (KS) in humans.
In 1994, a novel gammaherpesvirus, Kaposi's sarcoma-
associated herpesvirus (KSHV), was identified in both
classical KS (HIV-independent) and AIDS-KS (HIV-associ-
ated). Epidemiological studies have demonstrated that
KSHV is the etiological agent of all forms of KS, although
HIV and the associated immunodeficiency syndrome are
believed to be important co-factors in AIDS-KS. We have
previously identified the macaque homolog of KSHV,
called RF-associated herpesvirus (RFHV), in SRV-2 associ-
ated RF lesions [23] suggesting that RFHV may play an eti-
ologic role in SAIDS-RF. However, SRV-2 is highly
associated with SAIDS-RF and SRV-2 DNA is present in RF
tumor lesions [12], suggesting that SRV-2 infection and
the resulting immunodeficiency syndrome may play an
important co-factor role in the development of RF.Virology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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Table 1: Macaque sources of SRV-2 isolates
SRV 
Serogroup/
Subtype
Animal/Virus Isolate Species1 Origin2 RF3 Sample Date4 Comments
SRV-1 RM 18610/ D1/RHE/CA Mmu CA/cb - Tissue homegenate/ in vivo passage 1983 [Genbank:M11841] 
[6]
SRV-3 D3/RHE/WI Mmu WI - Breast tumor 1970 Mason-Pfizer 
monkey virus 
(MPMV) 
[Genbank:M12349] 
[2]
SRV-2A D2/CEL/OR Mni OR + PBMC/Raji culture 1985 [Genbank:M16605] 
[14]
-2A Mm_Mich Mmu MI - Spleen 1997
-2A NM101 Mfa NM/cb + Tongue 2004
SRV-2B D2/RHE/ORV1 Mmu OR - PBMC/Raji culture 1989 [Genbank:AF126468
] [15] → severe 
SAIDS in rhesus
-2B D2/RHE/OR Mmu OR - PBMC/Raji culture 1986 [Genbank:AF126467
] [16] → mild SAIDS 
in rhesus
-2B YN91-224 Mmu Yerkes/cb + RF tumor 1991 Experimentally 
infected with SIV in 
1989
-2B 90167 Mne WA/tr + RF tumor 1995
-2B T82422 Mne WA/cb + RF tumor 1984 Diagnosed with RF/
SF5
-2B M78114 Mne WA/cb + RF/SF tumor 1984 Diagnosed with RF/
SF [68]
-2B D2/MNE/WA Mne WA/cb + RF tumor 1982 [17]
SRV-2C 442N Mne NIH/tr + RF tumor 1996 Experimentally 
infected with SHIV in 
1996 [24]
-2C 17915 Mne NIH/tr - PBMC 1996
-2C 91048 Mfa WA/tr - PBMC 1997
SRV-2D F90346 Mne WA/cb - PBMC 1992 Same parents as 
F91249
-2D F89336 Mne WA/cb - PBMC/A549 culture 1994 Same father as 
F91249 and F90346
-2D F91249 Mne WA/cb - PBMC/A549 culture 1991 Same parents as 
F90346
SRV -2E A94040 Mfa WA/tr - PBMC 1997 Transferred to WA 
in 1994, SRV-2 
positive, mother of 
M96026
-2E M95332 Mfa WA/cb - PBMC Spleen 1997 2003
-2E M95348 Mfa WA/cb - PBMC 2003 Same father as 
M96020 and M96026
-2E M96020 Mfa WA/cb - Tonsils 2003 Same father as 
M95348 and M96026
-2E M96026 Mfa WA/cb - PBMC 2003 Child of A94040; 
same father as 
M95348 and M96020
SRV-2F SRV_sing31.2 Mfa Singapore
/wc
- PBMC 2003 Sampled in wild
1Species of macaque from which the sample was taken. Mne = Macaca nemestrina; Mmu = Macaca mulatta; Mfa = Macaca fascicularis; Mni = Macaca 
nigra;
2Primate center origin: WA = Washington NPRC; Yerkes = Yerkes NPRC; OR = Oregon NPRC; NIH = National Institutes of Health, Bethesda 
MD; MI = University of Michigan; NM = Lovelace Respiratory Research Institute, New Mexico; Singapore = sampled in the wild on the island of 
Singapore; wc = wild caught; cb = colony born; tr = transferred
3RF = diagnosed with retroperitoneal fibromatosis
4Date = approximate date sample obtained
5RF/SF = diagnosed with retroperitoneal and subcutaneous fibromatosisVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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SRV-2 associated SAIDS-RF has been observed in a variety
of macaque species, including pig-tailed, rhesus,
cynomolgus, Japanese and Celebese black macaques at
different NPRCs in the United States. Analysis of a
number of SAIDS-RF cases at the Washington NPRC
revealed the presence of a single SRV-2 variant (D2/MNE/
WA) associated with the RF lesions in pig-tailed macaques
[17]. However, the SRV-2 variant D2/CEL/OR was also
associated with SAIDS-RF in Celebes black macaques at
the Oregon NPRC [13]. Sequence comparisons revealed
significant differences between the partial env sequence of
the D2/MNE/WA and the corresponding sequence of D2/
CEL/OR [17], suggesting that multiple SRV-2 subtypes
could be associated with SAIDS-RF. However, the molec-
ular make-up of SRV-2 isolates associated with the various
SAIDS-RF cases in different macaque species at different
NPRCs has not been examined.
Despite the identification of KSHV as the etiological agent
of KS, much remains unknown regarding KSHV transmis-
sion, life cycle and pathogenesis, and the role of retrovirus
infection and immunodeficiency in disease progression.
This is in large part due to the lack of a relevant animal
model. Our long-term goal is to develop a macaque
model of AIDS-KS using the KSHV homolog, RFHV, as an
etiological agent to induce RF. Although it appears that
SRV-2 plays an important role in the development of RF,
it is not clear whether there is an optimal pathogenic SRV-
2 subtype for disease induction. In this study, we have
amplified and sequenced the complete SRV-2 env genes
from four different species of macaques, with and without
RF, from multiple NPRCs and the wild. We present here a
detailed comparative sequence analysis of the different
isolates and analyze their association with SAIDS-RF. We
further examine the possible biological impact of
sequence variation between isolates with respect to the
functional domains of the envelope glycoprotein.
Results
Amplification, cloning and sequence analysis of the 
complete env genes of a wide variety of SRV-2 isolates
We have collected a number of RF tumor and non-tumor
samples from different SRV-2 infected macaque species
from a variety of sources, including captive macaques
from six different US primate research centers and wild-
caught animals from Singapore (Table 1). The tissue sam-
ples ranged from freshly frozen tissue from recent necrop-
sies to 20–30 year old formalin-fixed paraffin-embedded
tissue sections. Genomic DNA was isolated and used in
PCR amplification to obtain full-length nucleotide
sequences of the SRV-2 env genes. In some cases, sample
amount and degradation limited our ability to obtain the
full length sequence. We have analyzed the deduced
amino acid sequences from these isolates and have com-
pared them with the complete env gene sequences previ-
ously identified for an SRV-1 isolate from a rhesus
macaque from the California NPRC (D1/RHE/CA; [6]),
an SRV-3 isolate from a rhesus macaque from the Wiscon-
sin NPRC (D3/RHE/WI; [2]), an SRV-2 isolate from a
Celebes black macaque (D2/CEL/OR; [14]), and two
closely related SRV-2 isolates from rhesus macaques (D2/
RHE/OR and D2/RHE/OR/V1; [15,16]) from the Oregon
NPRC. Additional partial env gene sequences previously
identified from SRV-2 isolates of pig-tailed macaques at
the Washington NPRC (D2/MNE/WA) [17] were also
included in the comparison.
Identification of six molecular subtypes of SRV-2 in captive 
and wild-caught macaque species by phylogenetic analysis 
of env gene sequences
We determined the complete sequence of the env gene
from sixteen different SRV-2 isolates and the sequence of
the C-terminal half of the env gene for an additional two
SRV-2 isolates. The resulting eighteen env gene sequences
were multiply aligned with the SRV-1, SRV-2, and SRV-3
prototype sequences obtained from the NCBI sequence
database (Genbank), as indicated above. Using the dis-
tantly related simian sarcoma virus (SSV) env  gene
sequence as outgroup, we performed a phylogenetic anal-
ysis using the protein maximum-likelihood method. All
of the putative SRV-2 sequences amplified from our tissue
samples clustered closely together and were clearly dis-
tinct from the SRV-1 and SRV-3 prototype sequences (Fig-
ure 1A).
A closer phylogenetic analysis of the SRV-2 sequences
revealed the presence of six separate clusters of sequences
(Figure 1B). These clusters represent six molecular sub-
types of SRV-2. The subtype SRV-2A cluster included the
original SRV-2 prototype, D2/CEL/OR, isolated from a
Celebes black macaque with SAIDS-RF at the Oregon
NPRC in 1985 [13], a closely related isolate obtained in
early 2000 from a cynomolgus macaque (NM101) with
SAIDS-RF from the Lovelace Respiratory Research Insti-
tute in New Mexico, and a more distantly related virus,
MmMich, obtained in the late1990's from a rhesus
macaque at the primate center at the University of Michi-
gan (see Table 1 for a description of viruses and their
macaque hosts). The SRV-2B cluster included the previ-
ously characterized closely-related SRV-2 isolates
obtained in the late 1980's from the rhesus macaque col-
ony at the Oregon NPRC, D2/RHE/OR and D2/RHE/OR/
V1 [15]. In addition, this cluster contained isolates
obtained in the early 1980's from two colony-born pig-
tailed macaques (M78114, T82422) at the Washington
NPRC, an isolate obtained in 1995 from a pig-tailed
macaque transferred from Indonesia to the Washington
NPRC (90167), and an isolate obtained in the mid 1990's
from a rhesus macaque (YN91-224) from the Yerkes
NPRC, which had all been diagnosed with SAIDS-RF. AlsoVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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included in this subtype were a number of isolates from
additional pig-tailed macaques with SAIDS-RF from the
WaNPRC for which only partial sequences have been
obtained (D2/MNE/WA) [17]. The SRV-2C subtype con-
tained a previously unknown isolate from a pig-tailed
macaque (442N) housed at the NIH primate center which
had been diagnosed with SAIDS-RF in 1996 [24]. In addi-
tion, SRV-2 virus obtained in the mid-1990's from
another pig-tailed macaque (17915) from the NIH, and
from a cynomolgus macaque (91048) from the Washing-
ton NPRC, both without RF, contained similar sequences
and grouped within the SRV-2C subtype. The SRV-2D sub-
type consisted of three virtually identical isolates obtained
in the early 1990's from closely-related healthy pig-tailed
macaques (F89336, F90346, and F91249) at the Washing-
ton NPRC. The SRV-2E subtype included isolates obtained
from five closely related cynomolgus macaques at the
Washington NPRC. Finally, the SRV-2F subtype consisted
of an isolate obtained in 2003 from a cynomolgus
macaque which had been sampled in the wild on the
island of Singapore. Closely related isolates were identi-
fied in other cynomolgus macaques from the same geo-
graphical area (Richard Grant, unpublished data).
Genetic variation of the env gene within SRV-2 subtypes
An alignment of the complete env sequence from proto-
types of each of the SRV-2 subtypes revealed identical sizes
(574 amino acids) and a high degree of conservation
throughout the entire protein (Figure 2). The genetic vari-
ation between the env genes from isolates within a specific
SRV-2 subtype was relatively small, with amino acid iden-
tities ranging from 97.3–100% (Table 2). In some cases,
few, if any, amino acid differences were detected between
the different isolates. This was true for the SRV-2F isolates
from an endemically infected group of wild macaques in
the same geographical area on the island of Singapore
(unpublished data, R. Grant) and for the SRV-2D and
SRV-2E subtypes where the different isolates came from a
single primate center during the same time period and
often consisted of macaques which were related through
the dame or sire. The SRV-2E subtype included an isolate
from A94040, a cynomolgus macaque that came to the
Washington NPRC from Texas and was SRV-2 positive at
that time, as well as isolates from descendents or siblings
of descendents sharing the same sire. The isolates from
A94040 and her child, M96026, were identical in
sequence, while only 1–3 amino differences were
observed with isolates from her child's half-siblings,
M95348 and M96020 who shared the same sire. The SRV-
2D subtype isolates from pig-tailed macaques F91249 and
F90346 were identical and varied at only one amino acid
position from F89336, which shared the same sire. While
the isolates from F91249 and F90346 were amplified
directly from peripheral blood leukocytes, the isolate
from F89336 was obtained from an uncloned Raji cell tis-
sue co-culture which had been maintained in A549 cells
since 1996. Isolate F89336 serves as a reference strain
within the Washington NPRC.
In the other subtypes, isolates obtained from different pri-
mate centers, from different macaque species and at differ-
ent time periods were remarkably similar. In subtype SRV-
2A, the original SRV-2 prototype, D2/CEL/OR, isolated by
Raji cell co-culture of PBMC from a Celebes black
macaque at the Oregon NPRC in the early 1980's, had
only eight amino acid differences with an isolate
(NM101) obtained 20 years later from a tissue sample of
a cynomolgus macaque from the Lovelace Respiratory
Research Institute in New Mexico. An additional SRV-2A
isolate was obtained in the mid 1990's from a tissue sam-
ple of a rhesus macaque in a primate center at the Univer-
sity of Michigan. Although only the C-terminal half of this
sequence was obtained, significant similarity with the
other two SRV-2A isolates was noted. In subtype SRV-2B,
two isolates (M78114, T82422) from the early 1980's,
sequenced directly from PBMCs of colony-born pig-tailed
macaques at the Washington NPRC, were identical in
sequence. A third isolate (90167) obtained from PBMCs
of a pig-tailed macaque at the same site ten years later var-
ied by only one amino acid. This later macaque was cap-
tured in Indonesia and transferred to the Washington
NPRC, suggesting that it became infected with the SRV-2B
subtype already present in the colony. An SRV-2B isolate
obtained from RF tissue of a rhesus macaque at the Yerkes
NPRC in 1991 had only one amino acid difference com-
pared to the M78114 and T82422 isolates from pig-tailed
macaques obtained in 1984 at the Washington NPRC. The
SRV-2B prototype, D2/RHE/OR, and the closely related
D2/RHE/OR/V1, which were obtained by Raji-cell co-cul-
ture from PBMCs, contained four and nine amino acid
differences, respectively, with the Washington isolates.
Two closely-related SRV-2D isolates were obtained from
the NIH primate center in Bethesda, MD. The SRV-2D pro-
totype was obtained in 1996 from RF tissue of pig-tailed
macaque 442N while the 17915 isolate was obtained
from PBMCs from another NIH pig-tailed macaque. These
two sequences varied at four amino acid positions. A par-
tial env sequence was obtained in 1997 from PBMCs from
a cynomolgus macaque (91048) which had been trans-
ferred to the Washington NPRC from Indonesia. This
sequence varied from the 442N prototype by five amino
acids within the c-terminal half.
Genetic variation of the env gene between different SRV-
2 subtypes
Pairwise comparisons of the different subtype env
sequences revealed amino acid conservations ranging
from 96.7% between subtypes A and E and between sub-
types B and D, to 93.6% between subtypes E and F (Table
2). Seventy-two amino acid positions (13% of the entireVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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sequence) showed differences in at least one of the
sequences analyzed, while fifty-five of these differences
occurred in more than one of the sequences. A compari-
son using the seventy-two variant positions visually dem-
onstrated the basis of the sequence differences between
the six subtypes (Figure 3). Some of these sequence differ-
ences were conserved within a specific subtype. For exam-
ple, at amino acid position 33 an isoleucine (I) was
conserved in all of the SRV-2B isolates, while a leucine (L)
was conserved in all of the SRV-2E isolates (Figure 3). On
the other hand, some amino acids were conserved across
subtypes, as seen in the SRV-2A, SRV-2C, SRV-2D, and
SRV-2F sequences which all contained a methionine (M)
at aa33. Frequently, there were single amino acid differ-
ences in one isolate within a subtype which were not con-
served in the other isolate sequences, i.e. glycine (G) at
aa29 in the M95348 isolate of subtype SRV-2E. Due to the
fact that in most cases PCR amplification products were
sequenced directly, without cloning, these differences
would not reflect Taq polymerase errors.
Genetic variation of SRV-2 within an individual infected 
macaque
In order to determine the genetic variation of SRV-2
within the same animal, multiple clones of a PCR ampli-
fication product encoding a 439 aa fragment of the env
gene were characterized from two different macaques
(F91249, T82422). Eight different clones were obtained
from each animal. Sequence analysis of each clone
revealed random nucleotide differences between each
cloned DNA within an animal (data not shown). How-
ever, no nucleotide difference occurred in more than one
clone, suggesting that the observed differences were the
result of errors induced by Taq polymerase during the PCR
amplification step. These data revealed no evidence for
the presence of multiple strains of SRV-2 within a single
individual.
We further analyzed the genetic variation within an SRV-
2 strain from an individual macaque over time. Two tissue
samples from macaque M95332 which contained an SRV-
2E subtype had been collected at two time points six years
apart, thus spanning the evolution of this virus over the
time frame from 1997–2003. The complete env gene was
amplified from each of these samples and compared. No
differences were detected between the two sequences. Fur-
thermore, we compared the isolate in M95332 with the
isolates from two animals in the same cohort, M96020
and M96026, and the mother of M96026, A94040, who
presumably introduced this SRV-2E isolate into the Wash-
ington NPRC colony nine years before the last M95332
isolate was sequenced. This comparison revealed only one
amino acid difference between the sequence of M95332
and those of M96020, M96026 or A94040, showing very
little variation within this SRV-2E strain even between dif-
ferent animals.
Structural conservation of the env gene between different 
SRV-2 subtypes
The SRV-2 env gene encodes a precursor polypeptide that
undergoes both glycosylation and proteolytic processing
during a maturation process that results in the expression
of the mature membrane-bound glycoprotein integrated
within the virion envelope. The envelope glycoprotein
interacts with host cellular receptors to initiate virus
adsorption and penetration, and plays an important role
in determining cell and tissue tropism. Thus, sequence
variation in the env gene can ultimately affect or deter-
mine the pathogenic potential of the virus. Interestingly,
Phylogenetic analysis of env sequences from different SRV-2  isolates Figure 1
Phylogenetic analysis of env sequences from different 
SRV-2 isolates. (A) A phylogenetic tree of reference SRV-1, 
SRV-2 and SRV-3 env protein sequences and sequences 
obtained from the SRV-2 isolates in this study (see Table 1) 
was generated from a ClustalW multiple alignment using the 
protein maximum-likelihood method as implemented in the 
Phylip package (v. 3.62). The sequence of the distantly related 
simian sarcoma virus (SSV) env protein was used as outgroup 
[Genbank:NC001514]. (B) A detailed phylogenetic tree of 
the SRV-2 reference and isolate sequences was similarly gen-
erated using SRV-3 as outgroup. Emerging clusters were 
labelled as subtypes SRV-2A through 2F and virus isolates 
from animals diagnosed with RF are indicated.
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91048-MfWA
17915_MnNIH
442N_MnNIH RF
M96020_MfWA
A94040_MfWA from TX
M96026_MfWA
M95348_MfWA
M95332_MfWA
NM101_MfNM RF
MmMich_MmMI
D2/CEL/OR_McOR RF
SRV-2D
SRV-2B
SRV-2F
SRV-2C
SRV-2E
SRV-2A
A.
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Multiple alignment of the complete env sequences of representative prototypes of the SRV-2 subtypes Figure 2
Multiple alignment of the complete env sequences of representative prototypes of the SRV-2 subtypes. A Clus-
talW alignment was generated using one representative prototype member from each of the six SRV-2 subtype clusters: SRV-
2A (D2/CEL/OR), SRV-2B (D2/RHE/ORV1), SRV-2C (442N), SRV-2D (F90346), SRV-2E (A94040), SRV-2F (SRV_sing31.2). 
The sequences of SRV-1 and SRV-3 were included for comparison. Dots represent amino acids identical to the reference 
sequence of the SRV-2A prototype. Conserved cysteine residues are shaded in yellow, while putative N-linked glycosylation 
sites (NXT/S) are shaded in black. The putative signal peptide, known T- and B-cell epitopes, heptad repeat, as well as the gp20 
fusion and transmembrane domains are indicated and referenced in the text. A predicted disulfide linkage within the immuno-
suppressive peptide, and the proteolytic cleaveage sites generating the gp70 surface and gp20 transmembrane subunits are indi-
cated. While B- and T-cell epitopes have been determined for SRV-2, the functions and locations of other domains are derived 
from studies in SRV-3.
                                                                                                        
                             20                  40                  60                  80          
SRV-2A   : MTLKDIPFWRVLLIFQTARVYAGFGDPREAITMIHQQHGKPCDCAGGYVNAAPTVYLAAVSCSSHTAYQPSDSLKWRCVSNPTLANGENI 
SRV-2B   : ................................I................IT.......T............................... 
SRV-2C   : ....N.........L...Q...............................T.......T............................... 
SRV-2D   : ..................................................T.......T............................... 
SRV-2E   : ..............L...Q.............L...R.............T...A...T............................... 
SRV-2F   : ..P.......I......................................ST.....I.T............................... 
SRV-1    : .NFNHHFT.SLVI.S.IFQ.Q.........LLE.Q.K............SSP..NS.TT....TY...SVTN....Q...T..T.SPTH. 
SRV-3    : .NFNYHFI.SLVILS.ISQ.Q.........LAE.Q.K............SSP.INS.TT....T....SVTN....Q...T..TPSNTH. 
                                                                                                        
                                                                                                        
                     100                 120                 140                  160                 
SRV-2A   : GNCPCKTFK---ESVHSSCYTAYQECFFGNKTYYTAILASNRAPTIGTSNVPTVLGNTHNLLSAGCTGN-VGQPICWNPKAPVHISDGGG 
SRV-2B   : .....Q...---.........T...............................................-.................... 
SRV-2C   : .........---............................K......A..............T...D..-..............V..... 
SRV-2D   : .....Q...---...............L.........................................-.................... 
SRV-2E   : ......I.Q---..................................................T......-.................... 
SRV_2F   : .....T...---......................................................I.S-.................... 
SRV-1    : .S..SQCNSQSYD...AT..NH..Q.TI.....L..TMIRDKS.SS.DG....I...NQ..II...PE.KK..VV...SQPS..M..... 
SRV-3    : .S..GECNTISYD...A...NH..Q.NI.....L..TITGD.T.A..DG.......TS...IT...PNGKK..VV...SRPS........ 
                                                                                                        
                                                                                                        
            180                 200                 220                  240                 260         
SRV-2A   : PQDKAREIAVQKRLEEIHKSLFPELRYHPLALPKARGKEKIDAQTFNLLTATYSLLNKS-NPNLANECWLCLPSGNPIPLAIPSNDSFLG 
SRV-2B   : ..................R........................................-.................V............ 
SRV-2C   : ........V..................................................-.............................. 
SRV-2D   : ..................R...........................D............-.................V.I.......... 
SRV-2E   : ...........................................................-.....S........................ 
SRV_2F   : ........V..................................................-.............................. 
SRV-1    : ....V...I.N.KF..L........S.......E.........H..D..ATVH....V.SQRQ..ED.....R..D.V...L.YDNTSCS 
SRV-3    : ......D.I.N.KF..L.R......S.......E.........H.LD..ATVH....A.-Q.S..ED.....Q..D.V...L.Y..TLCS 
                                                                                                        
                                                                                                        
                               280                 300                 320                       340     
SRV-2A   : S--------NLSCPIIPPLLVQPLEFMNLINASCFYSPFQNNSFDVDVGLVEFANCSTTLNIS------HSLCAPNSSVFVCGNNKAYTY 
SRV-2B   : .--------.................I.......L.........G........T....I....------..................... 
SRV-2C   : .--------..F..............IT.........................T....I....------Q.................... 
SRV-2D   : .--------.................S..T....L...S..............T....IF...------..............S...... 
SRV-2E   : .--------.................I..........................T....II...------..................... 
SRV_2F   : .--------.................T...........S...........AG.T....I....------................R.... 
SRV-1    : NSTFFFNCS.C..L.T..F....F---NFTHSV.L.ADY......I....AG.T...SYI...KPSSP---................... 
SRV-3    : N---FACLS.H...LT..F....F---NFTDSN.L.AHY......I....AS.T...SYY.V.TASKPSN.................... 
                                                                                                        
                                                                                                        
                           360                 380                 400                 420               
SRV-2A   : LPSNWTGTCVLATLLPDIDIVPGDAPVPVPAIDHYLHRARRAVQFIPLLVGLGITTAVSTGTAGLGYSITQYTKLSRQLISDVQAISSTI 
SRV-2B   : ..T......................................................................R................ 
SRV-2C   : ..T....................................................................................... 
SRV-2D   : ..T.........................................................................S............. 
SRV-2E   : ........................V................................................................. 
SRV_2F   : .......I.I................................................................................ 
SRV-1    : ..T....S............I..SE...I.....F.G.PK..I.....VI................V.L.......H............. 
SRV-3    : ..T....S............I..SE...I.....F.GK.K..I.L...F............A....V.........H............. 
                                                                                                        
                                                                                                        
                 440                 460                 480                 500                 520     
SRV-2A   : QDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCCFYANKSGIVRDKIKRLQEDLEKRRKEIIDNPFWTGLHGLLPYLLPLLGPL 
SRV-2B   : .......................................................................................... 
SRV-2C   : .......................................................................................... 
SRV-2D   : .......................................................................................... 
SRV-2E   : .......................................................................................... 
SRV_2F   : .............................................................R............................ 
SRV-1    : ......................................................N..D.......QL........F......VM...... 
SRV-3    : ......................................................N..D...R..RQL.......SF..F...VM...... 
                                                                                                        
                                                                                 
                           540                 560               
SRV-2A   : FCLLLLITFGPLIFNKIITFVKQQIDAIQAKPIQVHYHRLEQEDNGGVYLRVS 
SRV-2B   : L.................A.....M............................ 
SRV-2C   : L.................A............................I..... 
SRV-2D   : L.................A.................................. 
SRV-2E   : ..................A............................L..... 
SRV_2F   : L.................A.....ME.....................I..... 
SRV-1    : L....VLS...I....LM..I.H..ES.................H..S..NLT 
SRV-3    : L....VLS...I....LM..I.H..ES.................S..S..TLT 
signal peptide
cell receptor binding/B-and T-cell epitope T-cell epitope
T-cell epitope
dibasic aa proteolysis site
gp70 gp22/20
gp22 processing domain
transmembrane
heptad repeat
immunosuppressive peptide
fusion domain
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our data showed that 87% of the amino acids within the
574 amino acid env sequence exhibited no variation in the
different SRV-2 isolates examined (Figures 2 and 3).
Within the variant amino acid positions, in most cases,
only conservative changes were identified. The conserva-
tive nature of the env gene variability was further high-
lighted by the finding that, in many of the positions, the
variant amino acid in the SRV-2 isolate was an amino acid
found in either or both of the more distantly related SRV-
1 or SRV-3 serogroup prototypes. For example, leucine (L)
at aa193 was found only in one SRV-2B subtype isolate
but in both SRV-1 and SRV-3 prototypes. While for the
most part the variant positions were scattered evenly
throughout the env  sequence, several highly conserved
regions were identified. The N-terminal region aa60-aa95
was completely conserved between all SRV-2 isolates
examined (Figure 2).
Interestingly, this region was quite distinct from the
homologous regions in SRV-1 and SRV-3. The C-terminal
region from the putative N-linked glycosylation site at
aa345 to the C-terminus was extremely well conserved
among the SRV-2 isolates with only an occasional amino
acid variant. This conserved region within the SRV-2 iso-
lates is homologous to regions within the SRV-3 gp22/20
protein where several domains have been studied in
detail. Such domains include the gp70/gp20 proteolytic
site (aa382) [25], the known fusion domain (aa384-
aa410) [26], the heptad repeat region (aa409-aa462) [27],
the immunosuppressive peptide (aa443-aa477) [25,28], a
membrane spanning domain (aa516-532) [15], and the
region spanning the gp22 processing site (aa558) [25](see
Figure 2). In contrast to the conserved N-terminal region,
the C-terminal region was highly conserved not only
between SRV-2 subtypes but also with the SRV-1 and SRV-
3 sequences, with one region (aa419-aa485) completely
conserved between the isolates from the different SRV
serogroups. All twenty-two cysteine (C) residues were
conserved between SRV-2 isolates and the SRV-1 and SRV-
3 prototypes (Figure 3) indicating that all SRV serogroups
maintain the same basic disulfide-linked three-dimen-
sional  env  structure. SRV-1 and SRV-3 sequences con-
tained three additional conserved cysteine residues which
were not found in the SRV-2 isolates. Eleven putative N-
linked glycosylation sites (NXS/T) were conserved in all
the SRV-2 isolates and the SRV-1 and SRV-3 prototypes.
Sequence and structural conservation of an 
immunosuppressive peptide
To further explore the conservation detected in the C-ter-
minal region of the different SRV-2 subtypes and the SRV-
1 and SRV-3 serotypes, we searched the existing structural
databases for similar three-dimensional structures with
3D-PSSM [29] using the D2/CEL/OR subtype 2A
sequence as probe. 3D-PSSM is a program that uses a
threading algorithm to map the input sequence onto
known 3-dimensional structures based on several param-
eters including amino acid sequence, multiple align-
ments, and secondary structure predictions. A region of
the SRV-2 env polypeptide between amino acids 420–485
that was completely conserved in all SRV-2 isolates and in
the SRV-1 and 3 prototypes was found to have strong
structural homology to the C-terminal domains in the
envelope proteins of two other retroviruses, Moloney
murine leukemia virus (MMLV) and human T-lympho-
tropic virus (HTLV-1), as well as to a domain in the enve-
lope protein of Ebola virus, a ssRNA virus. The known
crystal structures of the MMLV, HTLV-1 and Ebola enve-
lope proteins revealed that these domains form a highly
conserved hairpin loop structure stabilized by a disulfide
bond [30-32]. This loop structure is believed to be respon-
sible for viral fusion with cellular membranes in several
virus species, some of which share little or no obvious
evolutionary relationship. Such viruses include the above
mentioned oncogenic retroviruses, the orthomyxovirus
influenza [33], the lentiviruses HIV-1 and SIV [34,35], the
paramyxovirus SV5 [36,37], and filoviruses [38]. Three-
dimensional structural predictions, using the Cn3D struc-
Table 2: Env sequence comparison of the SRV2-subtypes
SRV-2 Subtype Within subtype Between subtypes1
2B 2C 2D 2E 2F
2A 97.3–98.6% 96.2% 96.3% 96.5% 96.7% 94.8%
2B 98.3–100% - 94.9% 96.7% 94.8% 94.3%
2C 98.5–99.4% - - 95.5% 96.3% 94.3%
2D 99.0–99.8% - - - 95.3% 94.1%
2 E 9 9 . 1 – 9 9 . 8 % ---- 9 3 . 6 %
2 F 9 8 . 8 – 1 0 0 % -----
1The prototypes of each SRV-2 subtype, as indicated in the legend to Figure 2, were comparedVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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ture viewing program, revealed an almost perfect align-
ment between the structure predicted for the SRV-2
domain and the known crystal structures of the other pro-
teins, even though only nine amino acids in a 45 aa
stretch were conserved (Figure 4). The region correspond-
ing to the conserved domain within the SRV-2 isolates has
been previously identified as an immunosuppresive pep-
tide in several oncogenic retroviruses capable of inducing
an immuosuppressed state in their hosts (FeLV, MuLV,
REV-A) [39]. In addition, the entire gp20 protein of SRV-
3 has also been found to have immunosuppressive prop-
erties [40]. Studies with SRV-3 have revealed that residues
in the immunosuppressive peptide found within the gp20
protein subunit are responsible for binding to the gp70
protein subunit and are crucial for virus-cell fusion
[25,28].
Discussion
We investigated the genetic diversity of the serogroup 2
simian retroviruses (SRV-2) in four different wild-caught
or captive macaque species from six different primate
centers within the US over a 23 year time period. We iden-
tified at least six different SRV-2 subtypes by molecular
comparison of the complete env gene from twenty-two
different isolates. Our results indicate that separate intro-
ductions of at least six parental virus subtypes have
occurred in the captive macaque populations in the U.S.
with subsequent horizontal transfer between macaque
species and primate centers.
It is most likely that divergent SRV-2 strains were intro-
duced to the United States via importations of different
species of infected macaques from different geographical
areas. Procurement from common sources, close contact
in primate holding facilities, and traffic between primate
Alignment of variable amino acid positions within SRV-2 env sequences Figure 3
Alignment of variable amino acid positions within SRV-2 env sequences. This column alignment presents only those 
amino acid positions that vary in one or more of the twenty-one SRV-2 env sequences analyzed; exact position within the com-
plete env sequence (Figure 2) is indicated at the bottom of each column. The analogous amino acid positions of the closely 
related SRV-1 and SRV-3 sequences are shown for comparison. The macaque species, origin and RF status for each SRV-2 iso-
late are indicated on the right. Colored residues indicate the amino acid groupings upon which the phylogenetic analysis is 
based. Non-conserved amino acid variants are shaded (magenta). (Mne) Macaca nemestrina, (Mni) Macaca nigra, (Mfa) Macaca 
fascicularis, (Mmu) Macaca mulatta.
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SRV-3
D3/RHE/WI FYLSQEEQKSSNLTTNTSHIDDTAPKVVIILRDEVLLST—-SLYDASTSYYNNKTSVEAKHLNRGLKTIEQS
SRV-1
D1/RHE/CA FHLSQEEQKSSNLTTNSSHIDDIAPKVVMILKDEVLTCT—-SLYDAGTSYISNKTSVEAKHLNKGLKTIEQS
SRV-2
(B) D2/RHE/ORV1 LDVFREIHQITVLTEQTKTFNTSATNPVIAIRNNVLFSINIALFGVETTILHNKTTVAARRLRKGLKAMDQV -- Mmu OR
D2/RHE/OR VDVFREIHQITVLTEQTKTFNTSATTHVIAIRNNVLFSINIALSDVETTTLHNKTTVATKRFAKRLKAMDQV -- Mmu OR
YN91-224 LDVFREIHQITVLTKQTKAFNTSATNPVIAIRNNVLFSINIALSDVETTILHNKTTVAAKRLRKGLKAMDQV RF Mmu YE
90167 LDVFREIHQITVLTEQTKAFNTSATNPVIALRNNVLFSINIALSDVETTILHNKTTVAAKRLRKGLKAMDQV RF Mne WA
T81273 LDVFREIHQITVLTEQTKAFNTSATNPVIAIRNNVLFSINIALSDVETTILHNKTTVAAKRLRKGLKAMDQV RF Mne WA
M78114 LDVFREIHQITVLTEQTKAFNTSATNPVIAIRNNVLFSINIALSDVETTILHNKTTVAAKRLRKGLKAMDQV RF Mne WA
D2/MNE/WA SATNPGIADRNNVL RF Mne WA
(D) F90346 LDVFREMHQNTVLTEQTKALNTSATNPVIAIRDNVIFSSNTALSDVETTIFHSKTTVAAKSLRKGLKAIDQV -- Mne WA
F89336 LDVFREMHQNTVLTEQTKALNTSSTNPVIAIRDNVIFSSNTALSDVETTIFHSKTTVAAKSLRKGLKAIDQV -- Mne WA
F91249 LDVFREMHQNTVLTEQTKALNTSATNPVIAIRDNVIFSSNTALSDVETTIFHSKTTVAAKSLRKGLKAIDQV -- Mne WA
(C) 442N LNVLQEMHQNTVLTEKTKAFKATADNPVVVIKNNILFFITIAFFDVETTILQNKTTVAAKRLRKGLKAIDQI RF Mne NIH
17915 LNVLREMHQNTVLTEKTKAFKATADNPVVVIKNNILFSINIAFFDVETTILQNKTTVAAKRLRKRLKAIDQI -- Mne NIH
91048 ILFSINIAFFDVETTILQNKATVAAKRLRKGLKAIDLV -- Mfa WA
(A) D2/CEL/OR LDVFREMHQNAVLAEKTKAFNTSATNPVIAIKNNILFSMNIAFFDVEATTLHNKSTVAAKRLRKGFKTIDQV RF Mni OR
NM101 VDVFREMHQNAVLTEKTKAFNTSATNPIIAIKNNILVSMNIAFFDVEATTLHNKSTVAAKRLRRGLKAMDQV RF Mfa NM
Mm_Mich RNIVFFDVEAATLHNKTSVAAKRLRKGLKSIDQV -- Mmu MI
(E) A94040 LDVLQELHRNTALTEKIQAFNTTATNPVIAIKNSILFSINIAFFDVETTIIHNKSTVVAKRLRKGFKAIDQL -- Mfa TX
M96026 LDVLQELHRNTALTEKIQAFNTTATNPVIAIKNSILFSINIAFFDVETTIIHNKSTVVAKRLRKGFKAIDQL -- Mfa WA
M95332 LDVLQELHRNTALTEKIQAFNTTATNPVIAIKNSILFSINIAFFDVETTIIHNKSTVVAKRLRKGFRAIDQL -- Mfa WA
M95348 LDVLQGLYRNTALTEKIQAFNTTATNPVIAIKNSILFSINIAFFDVETTIIHNKSTVVAKRLRKGFRAIDQL -- Mfa WA
M96020 LDVLQELHRNTALTEKIQAFNTTATNPVIAIKNSILFSINIAFFDVETTIIHNKSTVVAKRLRKGFKAMDQL -- Mfa WA
(F) SRV_sing31.2 PDIFREMHQSTVITETTKAFNTSAISPVIVIKNNILFSTNIAFSDAGTTILHNRSIIAAKRLRRGLKAMEQI Mfa wildVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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centers would explain the spread of virus across the cap-
tive macaque populations and between macaque species.
The introduction of the SRV-2E subtype into the Washing-
ton NPRC provides one example for such a virus transfer
that was evident from our study. In 1994, a female
cynomolgus macaque, A94040, was purchased by the
Washington NPRC for breeding purposes. At the time of
transfer, this animal was negative for SRV-2 by serology
but was later shown to be positive by virus culture. Our
analysis of DNA from PBMCs collected in 1997 revealed
that A94040 was infected with an SRV-2E subtype, that
was not present in other macaques sampled at the Wash-
ington NPRC before 1994. The offspring of A94040,
M96026, born in 1996, became infected with SRV-2 and
analysis of PBMCs collected in 2003 revealed the presence
of an SRV-2E isolate identical to that of its mother. Our
analysis demonstrated that siblings with the same father
as M96026, but a different mother, were infected with
SRV-2E isolates that were nearly identical (1–3 aa differ-
ences) to that of M96026 and its mother A94040
Our data demonstrates that the env gene of SRV-2 is very
stable suggesting a remarkable adaptation of the virus to
its host. Within the five isolates of SRV-2E obtained from
a cohort of cynomolgus macaques at the Washington
NPRC, only 0–3 amino acid differences within the 574 aa
envelope protein were detected. In addition, we found no
evidence for variation of the viral env gene within a single
individual over a 6 year period. Surprisingly, even viral
isolates from different primate centers from different
macaque species separated in time by as much as 20 years
showed a high degree of conservation. The SRV-2B iso-
lates obtained seven years apart from the rhesus macaque,
YN91-224, at the Yerkes NPRC and the pig-tailed
macaque, T81273, at the Washington NPRC, differed by
only one amino acid. Our data confirm earlier studies
which showed a remarkable stability of the SRV-2 genome
over time by analysing partial env sequences in smaller
and more restricted samples [17,41].
The stability of the viral env gene over time within any
given subtype suggests that the different SRV-2 subtypes
evolved in the wild over long periods of time in segre-
grated primate hosts. Such segregation could be dictated
by constraints involving different geographical areas, dif-
ferent niches within the same geographical area, and/or
different natural host species. In our study, the natural
host species for only one of the SRV-2 subtypes was appar-
ent. The SRV-2F subtype was identified in a number of
cynomolgus macaques in the wild on the island of Singa-
pore. Interestingly, the SRV-2F subtype was clearly distinct
from all the subtypes present in captive populations of
cynomolgus, rhesus, Black celebes, or pig-tailed
macaques, suggesting that none of these five subtypes
originated from a cynomolgus macaque reservoir in Sin-
gapore. To date, no SRV-2 reservoir has been identified in
wild-living rhesus macaques which are native to India
[42]. Thus, the natural host species of SRV are likely to be
found in Southeast Asia. However, further analysis of
SRV-2 isolates directly from wild-caught animals is
needed to understand the natural reservoirs for these
viruses in more detail.
Our initial impetus to study the genetic variation within
the SRV-2 serotype was to determine whether there was an
association between virus subtype and SAIDS-RF. Our
data revealed that SAIDS-RF was associated with three
SRV-2 subtypes, 2A, 2B and 2C, in multiple species of
macaque, including pig-tailed, rhesus, cynomolgus and
Black celebes. A total of eight RF cases were examined
from five primate centers including the Washington, Ore-
gon, and Yerkes NPRCs, the NIH primate center and the
Lovelace Respiratory Research Institute in New Mexico.
While SRV-2A was associated with RF in celebes and
cynomolgus macaques, the SRV-2B subtype was associ-
ated with RF in pig-tailed and rhesus macaques. The SRV-
2C subtype was only associated with RF in pig-tailed
macaques. No obvious sequence similarities were
detected between the SRV-2A, -2B and -2C subtypes which
would correlate with the RF association. In two of the RF
cases, RF occurred soon after experimental infection with
SIV or SHIV. The rhesus macaque YN91-224 which was
infected with an SRV-2B subtype was diagnosed with RF
after undergoing an experimental infection with SIV at the
Yerkes NPRC (personal communication, H. McClure).
The SRV-2C infected pig-tailed macaque 442N was diag-
nosed with RF 24 weeks after infection with a pathogenic
strain of SHIV [24]. Thus, our studies revealed only an
association between the SRV-2A subtype and SAIDS-RF in
Black celebes macaques and between the SRV-2B subtype
and SAIDS-RF in pig-tailed macaques, in the absence of
other known immunodeficiency agents.
We have recently identified a single case of RF in a rhesus
macaque experimentally infected with a pathogenic strain
of SIV [43]. This animal was negative for all SRV serotypes
using type-specific qPCR assays. Additionally, four cases
of SAIDS-RF were reported in 1983 in a colony of Taiwan-
ese rock macaques at the New England NPRC which were
endemically infected with SRV-1 [44]. Similarly, a single
case of SAIDS-SF, the subcutaneous form of RF, was
reported in 1983 in a colony of rhesus macaques endem-
ically infected with the D1/RHE/CA subtype of SRV-1 at
the California NPRC [3]. Even though the vast majority of
RF cases in the different macaque colonies were associated
with SRV-2 serotypes, these findings suggest a broader role
for different SRV serotypes and possibly other retroviruses
such as lentiviruses as cofactors in the development of RF,
albeit with an apparent low efficiency.Virology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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Factors which are likely to play a major role in the devel-
opment of RF, include differences in the severity and type
of immunosuppression caused by an SRV-2 or lentivirus
infection, and co-infection with RFHV. Current data sug-
gests that the macaque herpesvirus, RFHV, may play a
causative role in the etiology of RF [23,45,46]. We have
developed PCR assays to detect the host-specific variants
of RFHV in rhesus (RFHVMm) and pig-tailed (RFHVMn)
macaques and have identified RFHV in RF lesions from
the macaques infected with both SRV-2B (T82422, 90167,
M78114, and YN91-224) and SRV-2C (442N) in this
study [[45], and unpublished results]. It is not known, at
this point, whether the macaque cohorts infected with the
SRV-2D, -2E and -2F subtypes which were not associated
with RF, were also co-infected with RFHV.
Differences in disease pathology and severity have been
observed in SRV-2 infections which could impact RF
development. Within a cohort infected with a single SRV-
2 subtype, different outcomes have been reported, includ-
ing a viremic state with rapid progression of SAIDS, a low-
grade viremia with a chronic milder form of the disease,
and a strong antibody response with no overt signs of dis-
ease [47]. Similarly, the same SRV-2 subtype can elicit dif-
ferences in disease severities in different macaque species.
The D2/CEL/OR isolate, for example, caused severe
immunodeficiency in Celebes black macaques, but when
the same isolate was transmitted to rhesus macaques, the
animals seroconverted and remained virus- and symp-
tom-free [13]. Conversely, the D2/RHE/OR isolate caused
mild disease in rhesus macaques but severe fatal immun-
odeficiency disease in Japanese macaques (Macaca fus-
cata). On the other hand, the closely related SRV-2B
isolates, D2/RHE/OR and D2/RHE/OR/V1, which differ
in only 17 amino acids over their entire genomes, were
found to induce vastly different disease outcomes in rhe-
sus macaques and to also display differences in tropism in
cell culture assays [15]. The D2/RHE/OR variant was asso-
ciated with only mild disease while the V1 variant caused
severe SAIDS.
In our study, the env sequence from the different SRV-2
isolates was highly conserved overall, with 93–96%
amino acid identity between isolates from different sub-
types and 97–100% amino acid identity between isolates
within a subtype. A hypervariable region was detected
between aa 284–321 near the C-terminus of the gp70 pro-
tein. Even within this variable region, most amino acid
changes were conservative or conserved with the SRV-1 or
SRV-3 sequences or both, underlining the stability of the
env protein. Interestingly, all potential N-linked glycosyla-
tion sites were conserved between the SRV-2 isolates, and
even with the related SRV-1 and SRV-3 serotypes. This is
in stark contrast to HIV and SIV which exhibit extreme var-
iation in number and precise location of N-linked glyco-
sylation sites [48]. Such variation is believed to be a major
pathway for immune evasion for lentiviruses. Thus, the
strict conservation of glycosylation sites between the vari-
ous SRV-2 isolates may help explain the high efficiency of
neutralizing antibodies against SRV-2 infections [49].
Our analysis showed that 15.5% of the amino acid posi-
tions within the receptor-binding surface-exposed (SU)
subunit gp70 were variable while only 8.7% of the amino
acid positions within the transmembrane (TM) subunit
gp22 differed between isolates. Differences were more
concentrated in the C-terminal portion of gp70 (last 100
aa) but also affected the N-terminal signal peptide
domain, as well as the known B- and T-cell epitopes
(aa96-102, aa127-153). The B- and T-cell epitope at aa96-
102 is of particular importance since naturally occurring
neutralizing antibodies to SRV-2 are directed against this
area [50] and it confers binding to the RD114/simian type
D retrovirus receptor, a neutral amino acid transporter
[51,52]. Three amino acid positions in this seven amino
acid domain displayed variations between isolates. We
identified three sequence variants within the T-cell
Structural and sequence alignment of the highly conserved  putative disulfide-bonded loop region of the SRV-2 env and  structurally similar regions of other viral envelope proteins Figure 4
Structural and sequence alignment of the highly con-
served putative disulfide-bonded loop region of the 
SRV-2 env and structurally similar regions of other 
viral envelope proteins. Structural similarities to the SRV-
2 env protein were identified by querying the NCBI protein 
structure database using 3D-PSSM and Cn3D. A region 
within the C-terminal domain of SRV-2 env which was identi-
cal in all SRV-2 isolates and SRV-1 and SRV-3 prototypes 
(aa426-471) was predicted to have structural similarities to a 
disulfide-bonded loop presumed to be important for virus-
cell fusion in a number of RNA viruses and retroviruses, 
including Ebola virus 1: 1EBO_A (Gp2); Ebola virus 2: 
2EBO_A (Gp2); MMLV (Moloney murine leukemia virus): 
1MOF (coat protein); HTLV-1 (human T-lymphotropic 
virus): 1MG1_A (gp21) (see text). The disulfide bridge is indi-
cated by S-S.
S-S
sdvqAISSTIQDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCcfyank D2/CEL/OR
ddlrEVEKSISNLEKSLTSLSEVVLQNRRGLDLLFLKEGGLCAALKEECafyad~ MMLV
kdisQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCcflnit HTLV-1
qlanETTQALQLFLRATTELRTFSILNRKAIDFLLQRWGGTCHILGPDCriephd Ebola
S-S S-S
sdvqAISSTIQDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCcfyank D2/CEL/OR
ddlrEVEKSISNLEKSLTSLSEVVLQNRRGLDLLFLKEGGLCAALKEECafyad~ MMLV
kdisQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCcflnit HTLV-1
qlanETTQALQLFLRATTELRTFSILNRKAIDFLLQRWGGTCHILGPDCriephd Ebola
sdvqAISSTIQDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCcfyank D2/CEL/OR sdvqAISSTIQDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCcfyank D2/CEL/OR
ddlrEVEKSISNLEKSLTSLSEVVLQNRRGLDLLFLKEGGLCAALKEECafyad~ MMLV ddlrEVEKSISNLEKSLTSLSEVVLQNRRGLDLLFLKEGGLCAALKEECafyad~ MMLV
kdisQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCcflnit HTLV-1 kdisQLTQAIVKNHKNLLKIAQYAAQNRRGLDLLFWEQGGLCKALQEQCcflnit HTLV-1
qlanETTQALQLFLRATTELRTFSILNRKAIDFLLQRWGGTCHILGPDCriephd Ebola qlanETTQALQLFLRATTELRTFSILNRKAIDFLLQRWGGTCHILGPDCriephd EbolaVirology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
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epitope at aa127-152, but only one difference in the 2nd T-
cell epitope located at aa233-249 [53]. Although some of
these differences are of conservative nature, the remaining
changes could affect the ability of the virus subtypes to
elicit an immune response and lead to differences in dis-
ease outcome.
The gp22 subunit was far less variable between isolates
than the gp70 subunit which likely is the result of sterical
restrictions imposed by a string of conserved functional
domains. The TM subunits of most retroviruses, including
SRV-3, contain an N-terminal hydrophobic fusion pep-
tide followed by a putative coiled coil-forming sequence,
a disulfide-bonded loop connected to a shorter C-termi-
nal alpha helix, a region with one or more N-linked glyc-
osylation sites, a hydrophobic membrane-spanning
sequence, and, as in SRVs, a cytoplasmic tail. Absolute
sequence conservation between different SRV-2 subtypes
and the SRV-1 and SRV-3 serotypes was seen within a
region of the C-terminal gp20 domain which has been
shown to be crucially important for the interaction
between the SU and TM domains and for the fusion of
viral and cellular membranes in MPMV. Using a threading
algorithm, we showed that the homologous region within
SRV-2, between aa426 and aa471, was structurally similar
to a region in other retroviruses including MMLV and
HTLV-1 [31,32,54] and the filovirus Ebola [38]. In these
and other distantly related retroviruses [34,35] as well as
in the orthomyxovirus influenza, the conserved disulfide-
bonded loop plays a highly pivotal role in stabilizing a
chain reversal which provides a hinge-like function that
brings the fusion peptide into proximity to the target cell
membrane during the fusion process [33]. We propose
that SRV-2, in analogy, uses a similar mechanism for host
cell membrane fusion.
Conclusion
In conclusion, our study revealed the presence of five SRV-
2 subtypes circulating among four macaque species held
in US primate centers. Three of these subtypes were asso-
ciated with RF in some macaque species, although a cor-
relation between sequence variation and disease could
not be established. A sixth and different subtype was
found in wild cynomolgous macaques on the island of
Singapore suggesting that the subtypes found in captive
macaques in the U.S. did not originate from this virus res-
ervoir. Since the viral subtypes discovered in captive mon-
keys did not display a macaque species specificity, the
nature of the original reservoir for these viruses is unclear.
Our studies also showed that the envelope protein of SRV-
2 was very stable suggesting a high degree of adaptation of
SRV-2 to its host. In all likelihood, simian retroviruses
have evolved very slowly in geographically distinct
macaque species, and only the physical contact with other
macaque species in captivity has allowed single virus sub-
types to spread between species.
Methods
Animals
Tissue samples were obtained from a variety of macaque
species naturally infected with SRV-2 that were housed at
different primate research centers in the U.S. over the last
twenty years. Some of these macaques were asympto-
matic, while others had been diagnosed with SAIDS-RF
(see Table 1). The tissue samples included RF tissue from
RF positive animals, tongue, spleen, tonsils and PBMCs or
PBMC/Raji cell co-cultures. Samples had been collected
over a wide time-range (1983–2003), starting at the
height of the SRV-2 epidemic in 1982–83. Macaque spe-
cies included pig-tailed macaques (Macaca nemestrina
(Mne)), Celebes black macaques (Macaca nigra (Mni)),
cynomolgous macaques (Macaca fascicularis (Mfa)) and
rhesus macaques (Macaca mulatta (Mmu)). Tissue sam-
ples were obtained from various primate research centers
including the Washington NPRC (Seattle, WA; C.-C. Tsai
and M.E. Thouless), Yerkes NPRC (Atlanta, GA; Harold
McClure), National Institutes of Health (Bethesda, MD;
Riri Shibata), Lovelace Respiratory Research Center (Albu-
querque, NM; Carole Emerson), University of Michigan
(Ann Arbor, MI; Nina Woodford); as well as one wild
cynomolgous macaque whose blood was drawn during a
catch-and-release process in the forests of Singapore (Uni-
versity of Washington; Lisa Jones-Engel).
DNA isolation
Frozen tissue samples or cell pellets were quickly thawed
in a standard proteinase K extraction buffer containing
0.1% SDS and vortexed. Paraffin-embedded formalin
fixed samples were first treated with xylenol to remove the
paraffin before extraction. Samples were digested over
night at 50°C and DNA was isolated by standard phenol/
chloroform extraction and ethanol precipitation.
PCR amplification, cloning and sequencing of the SRV-2 
env genes
To obtain the complete sequence of the different SRV-2
env  genes, template DNA was amplified by PCR using
SRV-2 specific primers. Primers srv2-env a (5'-CCTGAGAT-
CACTCCTTTTCTTTGCTCAT-3') and srv2-env1 b (5'-
CCGTCATTGGCTGACCAGTTTAG-3') were used to
obtain a 1,796 bp PCR product containing the complete
SRV-2 env sequence. In some cases, the primers srv2-env a
and srv2-env b (5'-CAGTTGAGACGGCAGTGGTT-3') were
used to obtain a 1,235 bp fragment which overlapped
with a 1,041 bp fragment obtained using srv2-env1 a (5'-
GAGTGCTGGCTATGCTTACCATC-3') and srv2-env1 b.
PCR fragments were purified with the GeneClean III Kit
(Q-Biogen) and directly used as templates in a sequencing
reaction.Virology Journal 2006, 3:11 http://www.virologyj.com/content/3/1/11
Page 13 of 15
(page number not for citation purposes)
To search for SRV-2 variants in the same animal, a 439 bp
fragment of the env  gene was PCR-amplified from
genomic DNA of two macaques (T82422, F91249) using
Platinum Taq polymerase and the primers: SRV2-env 1a
(5'-GAGTGCTGGCTATGCTTACCATC-3') and SRV2-env b
(5'-CAGTTGAGACGGCAGTGGTT-3'). The fragments
were subcloned into the pCR-Blunt vector (Invitrogen Life
Technologies, Carlsbad CA) using standard procedures.
Eight clones were obtained from each animal for sequence
analysis.
Sequencing was performed on an ABI model 310 auto-
mated sequencer with Prism Big Dye terminator cycle
sequencing ready reaction kit with Amplitaq DNA
polymerase FS (Applied Biosystems). DNA sequences
were analysed using Sequencher 4.1.4 (GeneCodes).
Sequence analysis
Multiple nucleotide and encoded amino acid alignments
were done with Vector NTI 9.0.0 (InforMax) based on the
ClustalW algorithm (EMBL, Heidelberg, Germany) or
with the ClustalW program [55] directly. The location of
the signal peptide was determined by SignalP 3.0 [56],
SigCleave [57], and iPSORT [58]. The location of trans-
membrane domains was determined with MEMSAT2 [59]
and Tmpred [60]. Putative glycosylation sites were deter-
mined with NetNGLyc 1.0 [61].
Three-dimensional structure analysis
The program 3D-PSSM [62] was used to identify proteins
with structural similarities to the SRV2 env prototype (D2/
CEL/OR). The structures for the six highest scoring pro-
teins were obtained from the Molecular Modeling Data-
base (MMDB)[63] which contains experimentally
determined three-dimensional biomolecular structures
obtained from the Protein Data Bank. Matching structures
were aligned with SRV2 env  using NCBI's 3D-structure
viewer Cn3D v4.1 [64]. Using NCBI's vector alignment
search tool (VAST)[65], we determined further protein
structure neighbors by direct comparison of 3-dimen-
sional protein structures stored in MMDB. This allowed us
to further evaluate possible structural and functional
domains of the SRV2 env protein.
Phylogenetic analysis
Multiple sequence alignments were performed with Clus-
talW [55]. Phylogenetic analysis of amino acid sequences
was done with protein maximum-likelihood (ProML)
method from the PHYLIP package version 3.62 of phylo-
genetic analysis programs (.)[66] (University of Washing-
ton, Seattle). Bootstrap analysis was performed using the
programs Seqboot and Consense from the PHYLIP pack-
age. The treefiles were displayed with TreeView [67]. Iden-
tical tree topologies were obtained by using neighbor-
joining analysis of the protein distance matrices and by a
parsimony method as implemented in the PHYLIP pack-
age. All of the major branch points were strongly sup-
ported by boot-strap analysis and statistical evaluations
within ProML.
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